MATCHING ADJUSTED INDIRECT COMPARISON BETWEEN DAPA-HF AND PARADIGM-HF FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION

被引：0
|
作者：
Qin, L. [1 ]
Young, R. [2 ]
Darlington, O. [2 ]
Song, B. [1 ]
McEwan, P. [2 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV17
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
    Jackson, Alice M.
    Dewan, Pooja
    Anand, Inder S.
    Belohlavek, Jan
    Bengtsson, Olof
    de Boer, Rudolf A.
    Boehm, Michael
    Boulton, David W.
    Chopra, Vijay K.
    DeMets, David L.
    Docherty, Kieran F.
    Dukat, Andrej
    Greasley, Peter J.
    Howlett, Jonathan G.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Ljungman, Charlotta E. A.
    Martinez, Felipe A.
    O'Meara, Eileen
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Tereshchenko, Sergey
    Verma, Subodh
    Jhund, Pardeep S.
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (11) : 1040 - 1054
  • [2] Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction An Analysis of DAPA-HF
    Jhund, Pardeep S.
    Ponikowski, Piotr
    Docherty, Kieran F.
    Gasparyan, Samvel B.
    Bohm, Michael
    Chiang, Chern-En
    Desai, Akshay S.
    Howlett, Jonathon
    Kitakaze, Masafumi
    Petrie, Mark C.
    Verma, Subodh
    Bengtsson, Olof
    Langkilde, Anna-Maria
    Sjostrand, Mikaela
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Sabatine, Marc S.
    Solomon, Scott D.
    McMurray, John J., V
    CIRCULATION, 2021, 143 (20) : 1962 - 1972
  • [3] The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction
    Verma, Subodh
    CARDIOVASCULAR RESEARCH, 2020, 116 (01) : E8 - E10
  • [4] Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF
    Butt, Jawad H.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Boer, Rudolf A.
    Bohm, Michael
    Desai, Akshay S.
    Howlett, Jonathan G.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Nicolau, Jose C.
    Petrie, Mark C.
    Ponikowski, Piotr
    Bengtsson, Olof
    Langkilde, Anna Maria
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Sabatine, Marc S.
    McMurray, John J., V
    Kober, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 513 - 525
  • [5] The Effect of Dapagliflozin on Anemia in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF
    Docherty, Kieran
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Feilpe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [6] Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials
    Shoji, Satoshi
    Kohsaka, Shun
    Shiraishi, Yasuyuki
    Kohno, Takashi
    Sawano, Mitsuaki
    Ikemura, Nobuhiro
    Niimi, Nozomi
    Nagatomo, Yuji
    Tanaka, Toshikazu D.
    Takei, Makoto
    Ono, Tomohiko
    Sakamoto, Munehisa
    Nakano, Shintaro
    Nakamura, Iwao
    Inoue, Soushin
    Fukuda, Keiichi
    Yoshikawa, Tsutomu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 359 : 76 - 83
  • [7] Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF
    Adamson, Carly
    Cowan, Lorna M.
    de Boer, Rudolf A.
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andre
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Ljungman, Charlotta E. A.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Lindholm, Daniel
    Bengtsson, Olof
    Boulton, David W.
    Greasley, Peter J.
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Solomon, Scott D.
    McMurray, John J., V
    Jhund, Pardeep S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1856 - 1868
  • [8] Effect of dapagliflozin on outcomes in women and men with heart failure with reduced ejection fraction in the DAPA-HF trial
    Butt, J. H.
    Kober, L.
    Docherty, K. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Langkilde, A. M.
    Martinez, F.
    Bengtsson, O.
    Ponikowski, P.
    Demets, D. L.
    Sjostrand, M.
    Sabatine, M. S.
    Solomon, S. D.
    Jhund, P. S.
    Mcmurray, J. John
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 9 - 10
  • [9] Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF
    Yeoh, S. E.
    Docherty, K. F.
    Jhund, P. S.
    Hammarstedt, A.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Solomon, S. D.
    Sattar, N.
    Welsh, P.
    Sabatine, M. S.
    Morrow, D. A.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 833 - 833
  • [10] Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study
    Gonzalez-Franco, Juliana
    Caicedo-Espinosa, Javier
    Cardona-Tobon, Carolina
    Jaramillo-Jara, Natalia
    Aguilar-Molina, Oswaldo
    Jaimes-Barragan, Fabian -Alberto
    Saldarriaga-Giraldo, Clara-Ines
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (02)
12345